Research & Innovation

June 13, 2023 In a national multicentre study, scientists at Lawson Health Research Institute and Western University are working to create rare isotopes that will be used as an important tool to help treat cancer. Currently, radiation therapy is a

March 10, 2023 A new study published in The Lancet Oncology suggests that a very precise, high-dose form of radiotherapy called stereotactic ablative radiotherapy (SABR) may be a new treatment option for patients with inoperable kidney cancer. Lawson

January 24, 2023 A Lawson Scientist and Schulich School of Medicine & Dentistry Associate Dean, Dr. Amit Garg is at the centre of two major grant announcements by the Canadian Institutes of Health Research (CIHR). The CIHR announced today that Dr

January 23, 2023 Lawson Health Research Institute is pleased to announce the results of the Fall 2022 Internal Research Fund (IRF) Competition . Over $160,000 has been awarded in this round, providing funding for 11 projects. “The IRF awards are

December 28, 2022 Published in the Journal of Cellular and Molecular Medicine , a team at Lawson Health Research Institute have discovered unique patterns of blood plasma proteins in critically ill patients that may help develop a more personalized

November 15, 2022 Published in the Lancet , findings from a large clinical trial through Lawson Health Research Institute (Lawson), ICES Western and Western University suggest that lowering dialysis temperatures does not lead to improved patient

November 10, 2022 A new study by researchers at ICES, Lawson Health Research Institute and Western University finds that virtual care during the COVID-19 pandemic led to a significant reduction in carbon dioxide emissions and patient travel-related

November 7, 2022 Recognized for his high-impact work over the past several years, Dr. Douglas Fraser has been named as Lawson Health Research Institute’s Scientist of the Year as part of the 2022 Lawson Impact Awards. Dr. Fraser, who is a Scientist

November 4, 2022 Cancer has touched Archie Verspeeten and his family, who have dedicated their philanthropy towards supporting advancements in cancer research through the London Health Sciences Foundation (LHSF). “My family has been affected by

November 3, 2022 Pancreatic cancer is one of the more challenging cancers to diagnose and treat. Even though medicine has come a long way regarding the treatment of pancreatic cancer, it is still difficult and progress in the diagnosis and treatment